Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesResMed Inc

ResMed Inc

Healthcare Medical Instruments & Supplies
PortfolioPortfolio WatchlistWatchlist
Company price
239.31 USD -1.20 ( 0.50%)
Last update at 2026-11-05T21:15:00Z
VOLUME
1668627
Market Cap
33097.25M
P/E
21.36

Momentum Score

…

ResMed Inc. engages in the digital health and cloud-connected medical devices business in the United States and internationally. It operates in two segments, Sleep and Breathing Health, and Residential Care Software. The company offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry; and EasyCare Tx, a sleep lab solution. It also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; and connectivity module which provides a cellular connection between compatible ventilation devices and AirView system. In addition, the company offers Brightree solutions which are solutions and services for organizations in home medical equipment and pharmacy, orthotic and prosthetic, and home infusion; HEALTHCAREfirst solutions that offers electronic health record, software, billing and coding services, and advanced analytics that enables home health and hospice agencies to optimize clinical, financial and administrative processes; MatrixCare EHR software as a service solutions used by skilled nursing and senior living providers, life plan communities, and home health and hospice sectors; and MEDIFOX DAN software solutions that is used by residential care providers, such as home health and nursing home providers. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
233.16
Low
246.68
High
52 Week Price Range
179.75
Low
281.89
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
240.51
Dividend Yield
1.08%
Revenue TTM
5653.44M
Revenue Per Share
38.85
Gross Profit TTM
3483.52M
Debt / Equity
0.13
ROE
24.27%
Net Debt
-643.32M
ROCE
25.74%
Diluted EPS TTM
10.74

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Income before tax 1919.42M 1677.57M 1264.80M 1101.66M 960.48M
Net income 1523.29M 1400.72M 1020.95M 897.56M 779.44M
Selling general administrative 1119.53M 991.02M 917.14M 874.00M 739.37M
Gross profit 3457.68M 3054.97M 2655.30M 2355.66M 2024.31M
Reconciled depreciation 244.15M 235.81M 216.21M 197.56M 193.84M
Ebit 1948.44M 1677.57M 1317.33M 1141.97M 1000.29M
Ebitda 2146.30M 1913.38M 1533.54M 1339.54M 1194.13M
Depreciation and amortization 197.86M 235.81M 216.21M 197.56M 193.84M
Operating income 1892.65M 1685.36M 1319.89M 1131.87M 1000.29M
Other operating expenses 3760.79M 3460.96M 3365.40M 3071.00M 2577.84M
Interest expense 29.03M 12.61M 45.71M 47.38M 22.31M
Tax provision 396.12M 276.84M 243.85M 204.11M 181.05M
Interest income - 2.54M 51.60M 44.72M 43.00M
Net interest income 49.91M 4.11M -45.71M -47.38M -22.31M
Income tax expense 396.12M 276.84M 243.85M 204.11M 181.05M
Total revenue 5653.44M 5146.33M 4685.30M 4222.99M 3578.13M
Total operating expenses 1565.03M 1369.61M 1335.41M 1203.66M 1024.03M
Cost of revenue 2195.77M 2091.36M 2029.99M 1867.33M 1553.82M
Total other income expense net 26.77M -7.80M -55.09M -2.95M -39.80M
Net income from continuing ops 1523.29M 1400.72M 1020.95M 897.56M 779.44M
Net income applicable to common shares - 1400.72M 1020.95M 897.56M 779.44M
Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Total assets 8965.95M 8174.39M 6872.39M 6751.71M 5095.85M
Intangible assets 452.74M 464.86M 485.90M 552.34M 345.94M
Other current assets 873.47M 377.78M 459.83M 437.02M 337.91M
Total liab 2380.56M 2206.53M 2008.35M 2621.80M 1735.10M
Total stockholder equity 6585.39M 5967.86M 4864.04M 4129.90M 3360.75M
Other current liab 536.08M 534.53M 377.68M 437.88M 389.62M
Common stock 0.76M 0.76M 0.59M 0.59M 0.59M
Capital stock 0.76M 0.76M 0.59M 0.59M 0.59M
Retained earnings 7255.12M 6081.49M 4991.65M 4253.02M 3613.74M
Other liab - - - 315.19M 160.03M
Good will 3362.31M 3046.68M 2842.05M 2770.30M 1936.44M
Other assets - 438.96M 403.66M 261.31M 202.29M
Cash 1469.23M 1209.45M 238.36M 227.89M 273.71M
Cash and equivalents - 1209.45M 238.36M - 273.71M
Total current liabilities 1395.11M 1019.12M 910.65M 758.53M 689.30M
Current deferred revenue 162.91M 166.03M 152.55M 138.07M 108.67M
Net debt -643.32M -357.64M 635.57M 1352.02M 643.84M
Short term debt 289.09M 40.41M 35.18M 31.82M 31.77M
Short long term debt 259.95M 9.90M 9.90M 9.90M 9.92M
Short long term debt total 825.92M 851.81M 873.93M 1579.91M 917.55M
Other stockholder equity -587.98M -39.69M 123.34M 148.83M 59.18M
Property plant equipment - 718.29M 699.15M 665.81M 630.50M
Total current assets 4324.74M 3505.61M 2357.72M 2367.83M 1931.48M
Net tangible assets - - - 807.26M 1078.37M
Short term investments - 13.08M 12.03M - -
Net receivables 1036.23M 990.67M 837.27M 704.91M 575.95M
Long term debt 399.42M 658.39M 697.31M 1431.23M 765.33M
Inventory 945.80M 927.71M 822.25M 998.01M 743.91M
Accounts payable 308.92M 278.16M 237.73M 150.76M 159.25M
Accumulated other comprehensive income -82.52M -74.70M -251.53M -272.53M -312.75M
Non currrent assets other -171.43M 100.81M 114.23M 395.43M 251.49M
Non current assets total 4641.21M 4668.79M 4514.68M 4383.88M 3164.38M
Capital lease obligations 166.55M 183.52M 166.72M 138.77M 142.31M
Long term debt total - 658.39M 697.31M - 765.33M
Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Investments -17.30M -200.04M -269.78M -1159.85M -13.92M
Change to liabilities - - - 31.34M -247.63M
Total cashflows from investing activities -545.20M -200.04M -269.78M -1159.85M -229.92M
Net borrowings -10.00M -40.00M -730.00M 665.00M 122.00M
Total cash from financing activities -1007.03M -606.25M -1119.29M 422.87M -128.36M
Change to operating activities - - - -138.12M -168.11M
Net income 1523.29M 1400.72M 1020.95M 897.56M 779.44M
Change in cash 259.78M 971.09M 10.47M -45.82M -21.57M
Begin period cash flow 1209.45M 238.36M 227.89M 273.71M 295.28M
End period cash flow 1469.23M 1209.45M 238.36M 227.89M 273.71M
Total cash from operating activities 1805.83M 1751.59M 1401.26M 693.30M 351.15M
Issuance of capital stock 74.50M 74.44M 53.09M 49.14M 47.38M
Depreciation 244.15M 235.81M 216.21M 197.56M 193.84M
Other cashflows from investing activities -12.41M 35.48M -15.40M -1025.85M -17.18M
Dividends paid 349.66M 310.88M 282.32M 258.28M 245.34M
Change to inventory -9.92M -80.17M 172.20M -248.83M -311.68M
Change to account receivables -96.78M -76.68M -134.28M -106.51M 19.35M
Sale purchase of stock -700.04M -300.02M -150.01M 1070.00M 47.38M
Other cashflows from financing activities -21.83M -29.79M -10.05M -32.99M 235.59M
Change to netincome - - - 60.31M 85.94M
Capital expenditures 156.28M 89.86M 114.86M 134.00M 156.04M
Change in working capital -74.24M 16.74M 44.78M -462.13M -708.08M
Stock based compensation 104.35M 91.66M 80.18M 71.14M 65.26M
Other non cash items 8.28M 6.66M 39.13M -11.05M 20.69M
Free cash flow 1649.54M 1661.72M 1286.40M 559.30M 195.11M

Peer Comparison*

Sector: Healthcare Industry: Medical Instruments & Supplies

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
RMD
ResMed Inc		 -1.20
0.50%		 239.31 21.36 18.59 5.85 4.88 5.58 14.64
ISRG
Intuitive Surgical Inc		 -13.58
2.82%		 468.52 43.30 31.35 12.25 7.35 11.63 30.22
ESLOF
EssilorLuxottica Société anonyme		 -
-%		 212.35 44.84 27.62 4.07 2.49 3.71 16.04
ESLOY
Essilor International SA		 -0.08
0.07%		 106.77 41.68 27.25 3.94 2.45 3.71 16.04
BDX
Becton Dickinson and Company		 4.36
2.08%		 213.55 31.62 13.76 2.25 2.04 2.93 13.40

Profile*

ResMed Inc

ResMed Inc. engages in the digital health and cloud-connected medical devices business in the United States and internationally. It operates in two segments, Sleep and Breathing Health, and Residential Care Software. The company offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry; and EasyCare Tx, a sleep lab solution. It also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; and connectivity module which provides a cellular connection between compatible ventilation devices and AirView system. In addition, the company offers Brightree solutions which are solutions and services for organizations in home medical equipment and pharmacy, orthotic and prosthetic, and home infusion; HEALTHCAREfirst solutions that offers electronic health record, software, billing and coding services, and advanced analytics that enables home health and hospice agencies to optimize clinical, financial and administrative processes; MatrixCare EHR software as a service solutions used by skilled nursing and senior living providers, life plan communities, and home health and hospice sectors; and MEDIFOX DAN software solutions that is used by residential care providers, such as home health and nursing home providers. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

9001 Spectrum Center Boulevard, San Diego, CA, United States, 92123

858-836-5000

https://www.resmed.com

11370

Name Title Year Born
Dr. Peter C. Farrell A.M., AM, B.E., BE (Hons), Ph.D., ScD Founder & Non-Exec. Chairman 1942
Mr. Michael J. Farrell BE, MBA, SM CEO & Director 1972
Mr. Robert A. Douglas Pres & COO 1960
Mr. Brett A. Sandercock Chief Financial Officer 1967
Mr. David B. Pendarvis Chief Admin. Officer, Global Gen. Counsel & Corp. Sec. 1959
Mr. Kaushik Ghoshal Pres of SaaS Bus. 1968
Ms. Urvashi Tyagi Chief Technology Officer NA
Ms. Constance C. Bienfait Director of Investor Relations NA
Ms. Amy Wakeham VP of Investor Relations & Corp. Communications NA
Ms. Vered Keisar Chief People Officer NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

DHT-U
CAD 13.53
+16.44%
LIF
CAD 22.04
+8.62%
TOI
CAD 103.80
+7.09%
CRON
CAD 5.26
+6.69%
CIA
CAD 2.04
+6.25%
ITH
CAD 1.61
-34.02%
IFOS
CAD 1.65
-22.90%
TNZ
CAD 49.70
-19.58%
KEEL
CAD 2.36
-19.45%
GIL
CAD 49.36
-18.33%

Equity Sectors*

  • Basic Materials

    -2.18%

  • Communication Services

    +0.95%

  • Consumer Cyclical

    -2.25%

  • Consumer Defensive

    -0.68%

  • Energy

    -2.93%

  • Financial Services

    -2.26%

  • Healthcare

    -0.46%

  • Industrials

    -3.70%

  • Real Estate

    -0.06%

  • Technology

    -3.32%

  • Utilities

    -0.50%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…